Sami Kilpinen, holder of the Ph.D. degree ( in bioinformatics, Faculty of Medicine, University of Helsinki ), is both the Chief Scientific Officer and a Cofounder of MediSapiens Ltd., a Finnish bioinformatics company focusing on applied personalized genomics in the pharmaceutical industry and in clinical application for personalized cancer care. He is also affiliated with Institute for Molecular Medicine Finland (FIMM). Previously he has contributed heavily to the development and teaching of bioinformatics courses both in the medical and bioscience faculties of University of Helsinki. He has also taught all minor and major level laboratory courses for genetics within the Faculty of Bioscience. On the academic side he has been part of research projects in Biomedicum Biochip Center, VTT/Medical Biotechnology, and the Academy of Finland Centre of Excellence in Translational Genome-Scale Biology Program, and in the past has also worked as a bioinformatics Advisor for the PamGene Corporation, The Netherlands. His area of focus in research is the development of applied approaches of synthesizing existing genomics knowledge into higher level of theories and resources, particularly in the field of personalized genomics and medicine. One of the most prominent results of this work is GeneSapiens (www.genesapiens.org)—the largest academic fully unified resource of the human transcriptome both in health and disease compiled entirely from existing expression data from over 10,000 samples across hundreds of published studies. Keywords describing his research interests are genome sequencing, transcriptomics, personalized cancer treatment, true reproducibility and applicability of published biological science for actual use, systematic approaches to store and analyze biological data, modeling of genomics level phenomena, and DNA level informatics.
Biography Updated on 20 June 2012